Cases 31 - 40 of 56
AbbVie Inc. et al v. Cipla Limited et al
as 1:2017cv01631
Plaintiff:
AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2017cv01199
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GmbH & Co. KG
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al
as 1:2017cv01065
Plaintiff:
AbbVie Inc. and AbbVie Biotechnology Ltd.
Defendant:
Boehringer Ingelheim International GMBH , Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim Fremont, Inc.
Cause Of Action: 35 U.S.C. § 145
AbbVie Inc. et al v. Aurobindo Pharma Limited et al
as 1:2017cv00047
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Amgen Inc. et al
as 1:2016cv00666
Plaintiff:
AbbVie Inc. and AbbVie Biotechnology Ltd.
Defendant:
Amgen Inc. and Amgen Manufacturing Ltd.
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. v. Amneal Pharmaceuticals, LLC et al
as 1:2016cv00398
Plaintiff:
AbbVie Inc.
Defendant:
Amneal Pharmaceuticals, LLC and Amneal Pharmaceuticals of New York, LLC
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Hetero USA Inc. et al
as 1:2015cv00889
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-III
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences Inc. et al v. AbbVie Inc.
as 1:2015cv00399
Plaintiff:
Gilead Sciences Inc. and Gilead Sciences Ireland Unlimited Company
Defendant:
AbbVie Inc.
Cause Of Action: 28 U.S.C. § 2201
In re: Gilead Pharmasset LLC
as 1:2014mc00243
Petitioner:
Gilead Pharmasset LLC
Respondent:
AbbVie Inc.
Cause Of Action: 28 U.S.C. § 1782
AbbVie Inc. v. Mylan Pharmaceuticals Inc.
as 1:2014cv01288
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
